The Medical and Pharmaceutical Industry Technology and Development Center (Pharmaceutical Technology Center) and PT. Sel Regenerasi Biotek signed a collaboration on April 8th. This partnership signifies a shared commitment to advancing regenerative medicine. With support from the Ministry of Economic Affairs' Industrial Technology Assistance Program, the Pharmaceutical Technology Center has become known for its innovative work in cell culture formulations, immune modulation, and neural repair stem cell processes. These achievements have solidified the center's reputation as an attractive partner for international collaborations.

Recognizing the vast potential of Indonesia, which boasts the largest economy in ASEAN with a population of 270 million, the partnership aims to capitalize on the nation's expanding healthcare market. By infusing vitality into Taiwan's expanding cell therapy industry, this collaboration is a pivotal step for both countries to penetrate the ASEAN market and unlock new avenues for the development of regenerative medicine.

Bintarna Tardy, Chairman of PT. Sel Regenerasi Biotek, unveiled plans to establish a subsidiary in Taiwan, working closely with the Pharmaceutical Technology Center to implement advanced processes for stem cells and extracellular vesicles. Leveraging Taiwan's extensive expertise in cell manufacturing, the subsidiary aims to accelerate the progress of clinical trials.

In facilitating this partnership, the Pharmaceutical Technology Center will provide invaluable support to PT. Sel Regenerasi Biotek's subsidiary in Taiwan during the preparation of pre-investigational new drug (pre-IND) data for cell preparations. This collaborative effort involves meticulous data gathering and organization, ensuring compliance with regulatory requirements before initiating clinical trials. Moreover, the center's involvement will have a positive impact on Indonesia's regenerative medicine sector. By fostering connections with domestic contract development and manufacturing organization (CDMO) companies specialized in cell production, the center will empower local Indonesian firms to seize international business opportunities and tap into the promising Southeast Asian market.